XORTX Therapeutics Investor Relations Material
Latest events
Investor Presentation
7 Jun, 2025
Q1 2025
15 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from XORTX Therapeutics Inc
Access all reports
XORTX Therapeutics Inc is a Canada-based clinical-stage biopharmaceutical company focused on developing therapies for chronic kidney disease and other health conditions related to abnormal purine metabolism and uric acid imbalance. The company’s lead drug candidates aim to lower serum uric acid levels to prevent or slow the progression of kidney and cardiovascular diseases. XORTX conducts research and clinical trials to advance its proprietary formulations. The company is headquartered in Calgary, Alberta, and its shares are listed on the NASDAQ.
Key slides for XORTX Therapeutics Inc
Investor Presentation
XORTX Therapeutics Inc
Investor Presentation
XORTX Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
XRTX
Country
🇨🇦 Canada